Asia Pacific Endomyocardial Biopsy Market Size & Outlook
Related Markets
Asia Pacific endomyocardial biopsy market highlights
- The Asia Pacific endomyocardial biopsy market generated a revenue of USD 69.6 million in 2024.
- The market is expected to grow at a CAGR of 10% from 2025 to 2030.
- In terms of segment, forceps was the largest revenue generating product in 2024.
- Forceps is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 69.6 million |
| Market revenue in 2030 | USD 123.4 million |
| Growth rate | 10% (CAGR from 2025 to 2030) |
| Largest segment | Forceps |
| Fastest growing segment | Forceps |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Forceps, Accessories |
| Key market players worldwide | Argon Medical Devices, Terumo Corp, Cardinal Health Inc, Scholten Surgical Instruments, Changzhou Lookmed Medical Instrument Co., Fehling Instruments |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 19.0% of the global endomyocardial biopsy market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 123.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Endomyocardial Biopsy Market Scope
Endomyocardial Biopsy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Fehling Instruments | View profile | 11-50 | Karlstein, Bayern, Germany, Europe | https://www.fehling-instruments.de |
| Changzhou Lookmed Medical Instrument Co. | View profile | 51-100 | Changzhou, Zhejiang, China, Asia | http://www.lookmedchina.com |
| Scholten Surgical Instruments | View profile | 1-10 | Lodi, California, United States, North America | https://www.novatome.com |
| Argon Medical Devices | View profile | 1001-5000 | Plano, Texas, United States, North America | http://www.argonmedical.com/ |
| Cardinal Health Inc | View profile | 48000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | https://www.cardinalhealth.com |
| Terumo Corp | View profile | 30207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | https://www.terumo.com |
Asia Pacific endomyocardial biopsy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endomyocardial biopsy market will help companies and investors design strategic landscapes.
Forceps was the largest segment with a revenue share of 79.17% in 2024. Horizon Databook has segmented the Asia Pacific endomyocardial biopsy market based on forceps, accessories covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is expected to register the fastest growth in the endomyocardial biopsy market during the forecast period owing to the increasing awareness about heart diseases and the need for early diagnosis & treatment.
Furthermore, improving healthcare infrastructure in the region has boosted the availability of endomyocardial biopsy services. Hospitals and diagnostic centers have been investing in advanced equipment and training their staff to perform these procedures, ensuring that patients have access to timely & accurate diagnostic services.
Furthermore, the lower cost of heart transplantation compared to other regions may increase the demand for heart transplantation-related medical tourism in Asia Pacific. As more patients undergo heart transplantation, there will be a corresponding increase in the number of patients that require post-transplant monitoring, such as endomyocardial biopsies.
Reasons to subscribe to Asia Pacific endomyocardial biopsy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific endomyocardial biopsy market databook
-
Our clientele includes a mix of endomyocardial biopsy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific endomyocardial biopsy market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific endomyocardial biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific endomyocardial biopsy market size, by country, 2018-2030 (US$M)
Asia Pacific Endomyocardial Biopsy Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
